Article
Benefits of Multifaceted Chemopreventives in the Suppression of the Oral Squamous Cell Carcinoma (OSCC) Tumorigenic Phenotype.
Cancer prevention research (Philadelphia, Pa.) - 1 Jan 2017
Mallery Susan R, Wang Daren, Santiago Brian, Pei Ping, Schwendeman Steven P, Nieto Kari, Spinney Richard, Tong Meng, Koutras George, Han Brian, Holpuch Andrew, Lang James
Abstract excerpt
Over one third of patients who have undergone oral squamous cell carcinoma (OSCC) surgical resections develop life-threatening and often untreatable recurrences. A variety of drugs, intended for management of recurrent or disseminated cancers, were designed to exploit cancer cells' reliance upon overexpressed receptors and gratuitous signaling. Despite their conceptual promise, clinical trials showed these agents...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
